We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-11.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$842M
AUM Growth
-$295M
Cap. Flow
-$112M
Cap. Flow %
-13.31%
Top 10 Hldgs %
47.05%
Holding
143
New
42
Increased
27
Reduced
21
Closed
50

Sector Composition

Rank Sector Weight
1 Healthcare 34.76%
2 Industrials 1.16%
3 Consumer Staples 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCKT icon
126
Rocket Pharmaceuticals
RCKT
$374M
-109,000
Closed -$2.48M
RVTY icon
127
PUT
Revvity
RVTY
$13.2B
-94,000
Closed -$9.13M
STAA icon
128
PUT
STAAR Surgical
STAA
$1.27B
-327,000
Closed -$11.5M
UNH icon
129
PUT
UnitedHealth
UNH
$364B
-94,000
Closed -$27.6M
NVRO
130
CALL
DELISTED
NEVRO CORP.
NVRO
-92,000
Closed -$10.8M
RCM
131
CALL
DELISTED
R1 RCM Inc. Common Stock
RCM
-163,000
Closed -$2.12M
AXNX
132
DELISTED
Axonics, Inc. Common Stock
AXNX
-163,490
Closed -$4.53M
NSTG
133
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
-654,000
Closed -$18.2M
SDC
134
PUT
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
-820,000
Closed -$7.17M
SPPI
135
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-218,000
Closed -$794K
HEXO
136
PUT
DELISTED
HEXO Corp. Common Shares
HEXO
-2,679
Closed -$239K
CSII
137
PUT
DELISTED
Cardiovascular Systems, Inc.
CSII
-218,000
Closed -$10.6M
XENT
138
CALL
DELISTED
Intersect ENT, Inc
XENT
-654,000
Closed -$16.3M
AGN
139
DELISTED
Allergan plc
AGN
-69,750
Closed -$13.3M
DERM
140
DELISTED
Dermira, Inc.
DERM
-110,350
Closed -$1.67M
HZNP
141
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-109,000
Closed -$3.95M
BHVN
142
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
-327,000
Closed -$17.8M

Similar funds

Pura Vida Investments's Q1 2020 Portfolio in Review

As of Q1 2020, Pura Vida Investments held 143 positions worth $842M, down 26% from $1.14B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments withdrew a net $112M in Q1 2020, closing 50 positions and reducing 21 holdings. Its most notable exit was Grifois, an estimated $13.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Pura Vida Investments opened a new position in AtriCure worth $13.1M.

  • Pura Vida Investments's largest Q1 2020 buy was AtriCure: 388,994 shares worth $13.1M.
  • Pura Vida Investments added most to Alexion Pharmaceuticals in Q1 2020, an estimated $11.9M increase.
  • Pura Vida Investments's biggest Q1 2020 reduction was DexCom, cutting an estimated $4.46M.
  • Pura Vida Investments fully exited Grifois in Q1 2020, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $842M portfolio in Q1 2020.
  • Pura Vida Investments opened 42 new positions and closed 50 in Q1 2020.
  • Pura Vida Investments's portfolio value fell 26% quarter-over-quarter to $842M.

Based on Pura Vida Investments's 13F filing for Q1 2020, filed 15 May 2020.